Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 30;3(Suppl):100-103.
doi: 10.1097/HS9.0000000000000236. eCollection 2019 Jun.

The diagnostic potential of the iron-regulatory hormone hepcidin

Affiliations

The diagnostic potential of the iron-regulatory hormone hepcidin

Andrew E Armitage et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Neither author has a conflict of interest to declare.

Figures

Figure 1
Figure 1
Potential utility of assessing hepcidin concentrations across clinical and physiological settings related to systemic iron homeostasis. Typical hepcidin concentrations vary considerably between diverse iron-related disorders and responses to distinct physiological challenges. Variation in hepcidin may aid differential diagnosis of distinct conditions with similar clinical presentations (here highlighted by fill color: yellow – iron deficiency / anemia / AI; blue – iron-loading disorders). Hepcidin may indicate the likely efficacy of response to iron interventions, and potentially whether oral or intravenous interventions should be preferred (when iron-overload is not indicated). In the future, hepcidin concentrations may guide the use of hepcidin antagonists (indicated by red outlines to boxes) or agonists (blue outlines) for disordered iron homeostasis. Note: in reality, there is likely considerable overlap in hepcidin concentrations between the conditions shown; the hierarchy shown is not intended to represent an exact order, but to give an indication of typical hepcidin concentrations (ie, typically raised vs normal vs suppressed) across the different conditions. AI = Anemia of Inflammation, CKD = Chronic Kidney Disease, HH = Hereditary Haemochromatosis – (HFE), caused by mutation in the HFE gene; (HJV/TfR2/HAMP), caused by mutations in Hemojuvelin, transferrin receptor 2 and hepcidin respectively, IBD = Inflammatory Bowel Disease, ICU = Intensive Care Unit, ID = Iron deficiency, IDA = Iron deficiency anemia, IRIDA = Iron-refractory iron deficiency anemia, LMIC = Low-/Middle-Income Country, NTDT = Non-transfusion dependent beta-Thalassemia, RA = Rheumatoid Arthritis, TDT = transfusion dependent beta-Thalassemia.

Similar articles

Cited by

References

    1. Muckenthaler MU, Rivella S, Hentze MW, et al. . A red carpet for iron metabolism. Cell 2017; 168:344. - PMC - PubMed
    1. Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood 2016; 127:2809. - PMC - PubMed
    1. Aschemeyer S, Qiao B, Stefanova D, et al. . Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood 2018; 131:899.Functional analysis of disease-causing and structure-guided engineered mutations in ferroportin indicating that besides triggering ubiquitination, hepcidin also impairs ferroportin-mediated iron transport directly by occluding its central cavity. - PMC - PubMed
    1. Zhang DL, Ghosh MC, Ollivierre H, et al. . Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress. Blood 2018; 132:2078.Experiments using erythroblast-specific ferroportin-knockout mice reveal that erythroblasts donate iron to serum via ferroportin, contributing to maintenance of systemic iron homeostasis while protecting erythrocytes from iron-induced oxidative stress. - PMC - PubMed
    1. Arezes J, Foy N, McHugh K, et al. . Erythroferrone inhibits the induction of hepcidin by BMP6. Blood 2018; 132:1473.Demonstration that hepcidin suppression by erythroferrone involves abrogation of BMP signalling through binding and inhibition of BMP6 and closely related BMP family members, BMP5 and BMP7. - PMC - PubMed